文献速递神经肿瘤

SARS-CoV-2进入因子在原代人胶质母细胞瘤中表达并在脑类器官模型中再现

SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models.
PubMed 文献 · J Neurooncol · 2023-01-03

研究评估SARS-CoV-2进入因子ACE2、TMPRSS2和NRP1在配对手术来源的胶质母细胞瘤组织、细胞系和类器官以及人脑来源标本中的表达,采用免疫组化、共聚焦像素线强度定量和转录组分析,发现患者来源胶质母细胞瘤组织和细胞培养表达这些进入因子,NRP1是最关键的促进SARS-CoV-2感染的因子,且受体表达在胶质母细胞瘤类器官中持续存在。

要点

  • 患者来源胶质母细胞瘤组织和细胞培养表达SARS-CoV-2进入因子ACE2、TMPRSS2和NRP1。
  • NRP1是胶质母细胞瘤中SARS-CoV-2感染最关键的促进因子。
  • 胶质母细胞瘤类器官保留受体表达,可作为研究该病毒对胶质母细胞瘤影响的模型。

核心结论

  • 研究提示SARS-CoV-2进入因子在原代组织和类器官模型中表达,可能用于研究胶质母细胞瘤对该病毒的易感性以靶向或调节肿瘤微环境。

研究设计与样本

  • 评估配对手术来源的胶质母细胞瘤组织、细胞系和类器官以及人脑来源标本中ACE2、TMPRSS2和NRP1的表达,采用免疫组化、共聚焦像素线强度定量和转录组分析。

主要发现

  • 患者来源胶质母细胞瘤组织和细胞培养表达SARS-CoV-2进入因子,NRP1是胶质母细胞瘤中SARS-CoV-2感染最关键的促进因子。
  • 受体表达在胶质母细胞瘤类器官中持续存在,使其成为研究该病毒对胶质母细胞瘤影响的 adequate 模型。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Glioblastoma (GBM) is the most common and malignant primary brain tumor in adults with a median overall survival of only 14.6 months despite aggressive treatment. While immunotherapy has been successful in other cancers, its benefit has been proven elusive in GBM, mainly due to a markedly immunosuppressive tumor microenvironment. SARS-CoV-2 has been associated with the development of a pronounced central nervous system (CNS) inflammatory response when infecting different cells including astrocytes, endothelial cells, and microglia. While SARS-CoV2 entry factors have been described in different tissues, their presence and implication on GBM aggressiveness or microenvironment has not been studied on appropriate preclinical models. METHODS: We evaluated the presence of crucial SARS-CoV-2 entry factors: ACE2, TMPRSS2, and NRP1 in matched surgically-derived GBM tissue, cells lines, and organoids; as well as in human brain derived specimens using immunohistochemistry, confocal pixel line intensity quantification, and transcriptome analysis. RESULTS: We show that patient derived-GBM tissue and cell cultures express SARS-CoV2 entry factors, being NRP1 the most crucial facilitator of SARS-CoV-2 infection in GBM. Moreover, we demonstrate that, receptor expression remains present in our GBM organoids, making them an adequate model to study the effect of this virus in GBM for the potential development of viral therapies in the future. CONCLUSION: Our findings suggest that the SARS-CoV-2 virus entry factors are expressed in primary tissues and organoid models and could be potentially utilized to study the susceptibility of GBM to this virus to target or modulate the tumor microenviroment.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Suarez-Meade P, Watanabe F, Ruiz-Garcia H, et al. SARS-CoV2 entry factors are expressed in primary human glioblastoma and recapitulated in cerebral organoid models. J Neurooncol. 2023. PMID: 36595192. doi:10.1007/s11060-022-04205-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。